HHGA
TEVA icon

Halbert Hargrove Global Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Halbert Hargrove Global Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-4,350
Closed -$271K – 188
2015
Q1 		$271K Buy
+4,350
New +$253K 0.09% 150
2014
Q2 		– Sell
-6,772
Closed -$358K – 138
2014
Q1 		$358K Buy
6,772
+542
+9% +$25.1K 0.11% 66
2013
Q4 		$250K Buy
+6,230
New +$245K 0.08% 108

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Halbert Hargrove Global Advisors's TEVA Position: Q2 2015 in Review

Halbert Hargrove Global Advisors sold out of Teva Pharmaceuticals (TEVA) in Q2 2015, closing a stake of 4,350 shares — an estimated $271K sold.

Halbert Hargrove Global Advisors first reported a position in TEVA in Q4 2013 and held it in 3 quarters. The position peaked at $358K in Q1 2014. 818 funds tracked by Wall St. Rank hold TEVA as of Q2 2015.

  • Halbert Hargrove Global Advisors reported no remaining Teva Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Halbert Hargrove Global Advisors sold 4,350 Teva Pharmaceuticals shares in Q2 2015, an estimated $271K.
  • Halbert Hargrove Global Advisors first reported a position in Teva Pharmaceuticals in Q4 2013 and held it in 3 quarters.
  • Halbert Hargrove Global Advisors's Teva Pharmaceuticals position peaked at $358K in Q1 2014.
  • 818 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2015.

Based on Halbert Hargrove Global Advisors's 13F filing for Q2 2015, filed 11 Aug 2015.